Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.
2.

Slow-Release Dexamethasone in Proliferative Vitreoretinopathy: A Prospective, Randomized Controlled Clinical Trial.

Banerjee PJ, Quartilho A, Bunce C, Xing W, Zvobgo TM, Harris N, Charteris DG.

Ophthalmology. 2017 Jun;124(6):757-767. doi: 10.1016/j.ophtha.2017.01.021. Epub 2017 Feb 23.

PMID:
28237428
3.
5.

Fibrotic encapsulation of a dexamethasone intravitreal implant following vitrectomy and silicone oil for rhegmatogenous retinal detachment.

Bakri SJ, Alniemi ST.

Ophthalmic Surg Lasers Imaging Retina. 2014 May-Jun;45(3):243-5. doi: 10.3928/23258160-20140501-02. Epub 2014 May 12.

PMID:
24806700
6.

A randomized controlled trial of combined 5-fluorouracil and low-molecular-weight heparin in management of established proliferative vitreoretinopathy.

Charteris DG, Aylward GW, Wong D, Groenewald C, Asaria RH, Bunce C; PVR Study Group.

Ophthalmology. 2004 Dec;111(12):2240-5.

PMID:
15582080
7.

Triamcinolone acetonide in silicone-filled eyes as adjunctive treatment for proliferative vitreoretinopathy: a randomized clinical trial.

Ahmadieh H, Feghhi M, Tabatabaei H, Shoeibi N, Ramezani A, Mohebbi MR.

Ophthalmology. 2008 Nov;115(11):1938-43. doi: 10.1016/j.ophtha.2008.05.016. Epub 2008 Jun 26.

PMID:
18584876
8.
9.
10.

Tamponade in surgery for retinal detachment associated with proliferative vitreoretinopathy.

Schwartz SG, Flynn HW Jr, Lee WH, Wang X.

Cochrane Database Syst Rev. 2014 Feb 14;(2):CD006126. doi: 10.1002/14651858.CD006126.pub3. Review.

11.

Outcomes of vitrectomy with inferior retinectomy in patients with recurrent rhegmatogenous retinal detachments and proliferative vitreoretinopathy.

Quiram PA, Gonzales CR, Hu W, Gupta A, Yoshizumi MO, Kreiger AE, Schwartz SD.

Ophthalmology. 2006 Nov;113(11):2041-7. Epub 2006 Sep 6.

PMID:
16952397
12.

Prevention and control of proliferative vitreoretinopathy: primary retinal detachment surgery using silicone oil as a planned two-stage procedure in high-risk cases.

Alexander P, Prasad R, Ang A, Poulson AV, Scott JD, Snead MP.

Eye (Lond). 2008 Jun;22(6):815-8. Epub 2007 Feb 2.

PMID:
17277751
13.

Preservation of anterior capsule during vitrectomy and lensectomy for retinal detachment with proliferative vitreoretinopathy.

MacCumber MW, Packo KH, Civantos JM, Greenberg JB.

Ophthalmology. 2002 Feb;109(2):329-33.

PMID:
11825819
14.

Inferior retinotomy and silicone oil tamponade for recurrent inferior retinal detachment and grade C PVR in eyes previously treated with pars plana vitrectomy or scleral buckle.

Mancino R, Aiello F, Ciuffoletti E, Di Carlo E, Cerulli A, Nucci C.

BMC Ophthalmol. 2015 Dec 9;15:173. doi: 10.1186/s12886-015-0167-z.

15.

Strategy for the management of complex retinal detachments: the European vitreo-retinal society retinal detachment study report 2.

Adelman RA, Parnes AJ, Sipperley JO, Ducournau D; European Vitreo-Retinal Society (EVRS) Retinal Detachment Study Group.

Ophthalmology. 2013 Sep;120(9):1809-13. doi: 10.1016/j.ophtha.2013.01.056. Epub 2013 Apr 17.

PMID:
23601805
16.

Pars plana vitrectomy and scleral buckle versus pars plana vitrectomy alone for patients with rhegmatogenous retinal detachment at high risk for proliferative vitreoretinopathy.

Storey P, Alshareef R, Khuthaila M, London N, Leiby B, DeCroos C, Kaiser R; Wills PVR Study Group.

Retina. 2014 Oct;34(10):1945-51. doi: 10.1097/IAE.0000000000000216.

PMID:
24999720
17.

Influence of relaxing retinotomy on surgical outcomes in proliferative vitreoretinopathy.

Tseng JJ, Barile GR, Schiff WM, Akar Y, Vidne-Hay O, Chang S.

Am J Ophthalmol. 2005 Oct;140(4):628-36.

PMID:
16226515
19.

Comparison of 1000-Centistoke versus 5000-Centistoke Silicone Oil in Complex Retinal Detachment Surgery.

Zafar S, Shakir M, Mahmood SA, Amin S, Iqbal Z.

J Coll Physicians Surg Pak. 2016 Jan;26(1):36-40. doi: 01.2016/JCPSP.3640.

PMID:
26787029
20.

Outcomes of surgery for retinal detachment associated with proliferative vitreoretinopathy using perfluoro-n-octane: a multicenter study.

Scott IU, Flynn HW Jr, Murray TG, Feuer WJ; Perfluoron study group.

Am J Ophthalmol. 2003 Sep;136(3):454-63.

PMID:
12967798

Supplemental Content

Support Center